News Headlines

  1. Veeva Announces MyVeeva To Enable Patient-Centric Clinical Trials 5/19/2020

    Veeva Systems today announced MyVeeva, a new application for clinical research sites.

  2. Veeva Announces Vault Site Connect To Automate Information Sharing In Clinical Trials 5/19/2020

    Veeva Systems today announced Veeva Vault Site Connect, a new application that connects sponsors and clinical research sites during trials.

  3. TrialScope’s Mike Wenger Named A 2020 PM360 ELITE 100 Patient Advocate 5/18/2020

    Mike Wenger, Vice President of Patient Engagement at TrialScope, has been named one of the 2020 PM360 ELITE 100 in the Patient Advocates category. The PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represents the most influential people in the healthcare industry today.

  4. Thermo Fisher Scientific To Double Its Capacity Of Viral Vector Manufacturing 5/15/2020

    To support increasing demand for viral vector development and manufacturing services, Thermo Fisher is expanding capacity with construction of a new commercial manufacturing site in Plainville, Mass. The 290,000-square-foot facility will more than double commercial viral vector capacity to support customers who are developing and manufacturing gene therapies and vaccines to address unmet medical needs.

  5. Karyopharm Donates 60,000 Medical Masks Across Massachusetts And The United States In Partnership With Family Reach, Myeloma Crowd And The Leukemia & Lymphoma Society 5/13/2020

    Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an innovation-driven pharmaceutical company, today announced a new initiative to donate and distribute 60,000 medical masks to some of the most vulnerable individuals impacted by the ongoing COVID-19 pandemic including cancer patients, their families, and the healthcare workers caring for them.

  6. LabCorp And Ciox Health Enter Collaboration To Create Comprehensive Patient Data Registry 4/29/2020

    LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, and Ciox Health, the leader in health information management for more than 30 years, today announced an agreement to collaborate on a comprehensive U.S.-based COVID-19 patient data registry. This registry will house curated, HIPAA-compliant de-identified data sets to expedite clinical research and analyses related to COVID-19. This patient data registry is expected to enable researchers to better understand and characterize COVID-19  diagnoses and treatments and generate insights that will aid ongoing and future pandemic preparedness and prevention efforts.

  7. ERT Offers First Patient-Administered ECG Assessment For Continuation Of Clinical Trials During COVID-19 4/23/2020

    ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a first-of-its-kind partnership with AliveCor, the leader in AI-based, personal ECG technology.

  8. Transperfect Life Sciences Announces Free Access To Trial Interactive Central And Remote Monitoring Solutions For Study Teams Impacted By COVID-19 4/23/2020

    TransPerfect Life Sciences, a leading provider of technologies and services to support clinical trials and product development for the biopharmaceutical industry, today announced that current and new Trial Interactive eTMF customers will have access to free remote and central monitoring solutions to assist study teams during the COVID-19 pandemic.

  9. Signals Analytics Powers Informa Pharma Intelligence’s Offerings With Next Generation Advanced Analytics 4/22/2020

    Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and Signals Analytics, the next generation advanced analytics platform that leverages external data to uncover trends and novel insights, today announced a joint offering that helps life sciences companies to identify new opportunities, mitigate investment risks and accelerate the drug development process

  10. Itamar™ Medical Funds Clinical Study To Evaluate Potential Impact Of CPAP Therapy To Patients With COVID-19 4/22/2020

    Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices, solutions and a digital health platform to aid in the diagnosis of respiratory sleep disorders, today announced the initiation of a funded trial that will evaluate the use of CPAP to manage patients with confirmed or suspected COVID-19.